Related Experiment Video
Updated: May 30, 2025
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
Published on: October 4, 2016
Transcranial Alternating Current Stimulation (tACS) for Major Depressive Disorder
Julie A Clancy1, Justin Riddle1, Paolo Cassano1
1Harvard Medical School, Department of Psychiatry, Boston, Massachusetts (JAC, PC); Division of Neuropsychiatry, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts (JAC, PC); Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (JR, FF); Carolina Center for Neurostimulation, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (JR, FF); Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts (PC); Center for Anxiety and Traumatic Stress Disorders, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts (PC); Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (FF); Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (FF); Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (FF); and Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (FF).
Transcranial alternating current stimulation (tACS) is a promising noninvasive neuromodulation technique for major depressive disorder (MDD). While requiring further research for clinical standardization, tACS offers a potential safe and effective alternative to traditional treatments.
Area of Science:
- Neuroscience
- Psychiatry
- Biomedical Engineering
Background:
- Major depressive disorder (MDD) is a significant psychiatric condition with ongoing research into novel treatment modalities.
- Device-based neuromodulation represents a growing area for psychiatric interventions.
Purpose of the Study:
- To explore the potential of transcranial alternating current stimulation (tACS) as a treatment for MDD.
- To assess tACS as a noninvasive, wearable, and low-cost alternative or augmentation to pharmacological treatments for MDD.
Main Methods:
- Review of current literature on transcranial alternating current stimulation (tACS).
- Analysis of tACS as a neuromodulation technique for psychiatric disorders, specifically MDD.
Main Results:
- Transcranial alternating current stimulation (tACS) shows potential as a safe and effective noninvasive neuromodulation method.
- Existing research suggests tACS could complement or replace pharmacological interventions for MDD.
Conclusions:
- Transcranial alternating current stimulation (tACS) is an emerging technology with significant promise for treating major depressive disorder (MDD).
- Further refinement of device parameters is necessary for the standardized clinical application of tACS in psychiatric care.
